본문 바로가기
  • Home

Cognitive Improvement Effect of Resplex Alpha A in the Scopolamine-induced Mouse Model

  • CELLMED
  • Abbr : CellMed
  • 2023, 13(14), pp.1-1
  • DOI : 10.5667/CellMed.2023.014
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : November 30, 2023
  • Accepted : November 30, 2023
  • Published : November 30, 2023

Bong-Keun Jang 1 Youngsun Kwon 1 Sunyoung Park 1 Gunwoo Lee 1 Hye-yeon Kang 1 Jeom-Yong Kim 1

1JBK-LAB, Inc.

Accredited

ABSTRACT

Administration of Scopolamine can be considered a psychopharmacological model of Alzheimer's disease (AD). We made an animal model of Alzheimer's disease (AD) by administering Scopolamine to Blab/c mice. In this study, we investigated the effects of Resplex Alpha on memory impairment and cognitive function in mice in a mouse animal model of Scopolamine-induced memory impairment. Through Y-mazed and passive avoidance behavioral assays, we observed that Resplex Alpha recovered Scopolamine-induced short-term memory and cognitive functions. The results of our study imply that Resplex Alpha may be beneficial in the prevention of Alzheimer's disease (AD).

Citation status

* References for papers published after 2022 are currently being built.